PerspectivePharmaceutical Toxicity

Improving Risk Assessment

See allHide authors and affiliations

Science Translational Medicine  07 Nov 2012:
Vol. 4, Issue 159, pp. 159ps22
DOI: 10.1126/scitranslmed.3003497

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to improve predictions of drug-related adverse events.

View Full Text